CTRI/2022/11/047322招募中3 期
Efficacy and safety of Ayurveda Formulation â??Trikatuâ?? in Dyslipidemia- A Prospective Randomized Double Blind Placebo Controlled Trial
Central Council for Research in Ayurvedic Sciences CCRAS0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Participants of any gender in the age group 30-60 years
- •2.Diagnosis of primary dyslipidemia (Total Cholesterol in the range of >200 <239 mg/dl, LDL-C > 100 <159 mg/dl.
- •3.Participants at low risk of ASCVD disease ( <5% 10 year risk) as assessed through ASCVD calculator
- •4.Body Mass Index (BMI) >= 18.5 and < 29.9 kg/m².
- •5.Written informed consent provided prior to screening, after receiving and understanding the subject information.
- •6.Willingness to adhere to the treatment for a period of 3 months
排除标准
- 未提供
研究者
相似试验
招募中
2 期
Safety and Efficacy of Trikatu, an Ayurvedic Formulation, as an Add-On to Standard Care for DyslipidemiaCTRI/2023/04/051942Central Council for Research in Ayurvedic Sciences Ministry of Ayush Govt of India
已完成
3 期
Impact of effect of Ayurvedic treatment Divya Phyter on Functional Constipation.CTRI/2023/02/049649Patanjali Research Institute governed by Patanjali Research Foundation Trust, Haridwar Uttarakhand207
尚未招募
3 期
To study the impact of ayurvedic formulation Divya Renogrit in patients with Kidney Impairemen: single arm, observational study.CTRI/2023/08/056320Patanjali Research Institute governed by Patanjali Research Foundation Trust
尚未招募
3 期
Effect of herbal formulation (Divya Cologrit Enteric-coated tablets) in inflammatory bowel disease.CTRI/2023/08/056244Patanjali Research Institute governed by Patanjali Research Foundation Trust
进行中（未招募）
3 期
Effect of Traditional Ayurvedic Formulation Divya Cystogrit in patient with Cysts, Fibroids and Benign tumor.CTRI/2023/01/048769Patanjali Research Foundation Trust